Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: gemcitabine|DRUG: paclitaxel|DRUG: carboplatin|DRUG: cisplatin
Sponsor: Eli Lilly and Company